You're listening to Tech Beat, your daily read on the technology stories that matter.
The biggest medical news of the day comes from Moderna and Merck, whose personalized mRNA cancer vaccine showed a forty-two percent reduction in death and recurrence for melanoma patients. That figure comes from late-stage trial data, and it marks a significant milestone for a technology that, until recently, most people only associated with COVID. The implications for oncology could be substantial.
Shifting from biology to silicon, a small company called TradeMAV is crowdfunding a device called RAMDeck on Indiegogo, priced at one hundred nine dollars for early backers. The pitch is that it pools the memory from your old PCs, Macs, and phones to run larger AI models locally. The catch worth knowing is that the engine underneath is llama.cpp's RPC backend, software anyone can already download and run for free today.
And on a different kind of fuel altogether, Chinese automaker GAC has been experimenting with a four-cylinder engine that runs on ammonia. The logic is cleaner combustion and easier storage compared to hydrogen, though the engineering challenges around corrosion and efficiency are considerable. It is a reminder that the race for alternative fuels is still genuinely open.
Keep surfing. Tech Beat out.
